APR January/February 2022 - 9

AMERICAN PHARMACEUTICAL REVIEW
Social Media Connections
FDA Drug Information
@FDA_Drug_Info
CDER experts discuss a series of draft guidances
on aspects of real-world data (RWD) and real-world
evidence (RWE) in regulatory decision-making in the
latest From Our Perspective: https://go.usa.gov/xtEDH
U.S. Pharmacopeia
@USPharmacopeia
How do we meet today's challenges & maximize opportunities
that better prepare us for the future? Learn
about USP's perspective on #BioPharmaceutical innovation,
advanced manufacturing technologies & global
health crisis #preparedness in @Chaindrugreview.
http://ow.ly/j5rV50Hs0Vm
PhRMA
@PhRMA
The biopharmaceutical industry is continuing to fight
COVID-19. Today, there are over 600unique therapies
currently in clinical trials. Protect yourself and your
community by getting the vaccine and a booster, and stay
updated at http://phrma.org/coronavirus
Pfizer Inc.
@pfizer
As part of ongoing efforts to address #Omicron & determine
the potential need for variant-based vaccines,
with our partner @BioNTech_Group, we initiated a
study evaluating an Omicron-based #COVID19 vaccine
candidate in adults 18 through 55. Learn more: https://
on.pfizer.com/3rHh2WA
Moderna
@moderna_tx
We are grateful to the @US_FDA for their thorough review
of our application. We are humbled by the role that
Spikevax™ is playing to help end this pandemic.
EU Medicines Agency
@EMA_News
Have you heard about the Clinical Trials Information
System or CTIS? This initiative will increase transparency
and better support medical research and innovation in
the EU. #EUClinicalTrials #HealthUnion #ClinicalTrials
CDC
@CDCgov
Data show that people who are fully vaccinated and
boosted against #COVID19 have the highest amount
of protection against both the Delta and Omicron
variants. Stay up to date with COVID-19 vaccination to
protect yourself and others. Learn more: http://bit.ly/
CDTweeklyreview.
Health Canada and PHAC
@GovCanHealth
Looking for Canadian studies about the health impacts of
#COVID19? Visit the COVID-19 virtual library of health data
and evidence to access studies related to health care, public
health, population health and health research. http://
ow.ly/vMj750HIwW4
Connect with American Pharmaceutical Review at:
facebook.com/AmericanPharmaceuticalReview
twitter.com/ampharmrev
linkedin.com/groups/American-Pharmaceutical-Review-3889659
www.americanpharmaceuticalreview.com |
| 9
https://go.usa.gov/xtEDH http://www.ow.ly/j5rV50Hs0Vm http://www.phrma.org/coronavirus http://https:// http://on.pfizer.com/3rHh2WA http://www.bit.ly/ http://http:// http://www.ow.ly/vMj750HIwW4 http://www.facebook.com/AmericanPharmaceuticalReview http://www.twitter.com/ampharmrev http://www.linkedin.com/groups/American-Pharmaceutical-Review-3889659 http://www.americanpharmaceuticalreview.com

APR January/February 2022

Table of Contents for the Digital Edition of APR January/February 2022

APR January/February 2022 - Cover1
APR January/February 2022 - Cover2
APR January/February 2022 - 1
APR January/February 2022 - 2
APR January/February 2022 - 3
APR January/February 2022 - 4
APR January/February 2022 - 5
APR January/February 2022 - 6
APR January/February 2022 - 7
APR January/February 2022 - 8
APR January/February 2022 - 9
APR January/February 2022 - 10
APR January/February 2022 - 11
APR January/February 2022 - 12
APR January/February 2022 - 13
APR January/February 2022 - 14
APR January/February 2022 - 15
APR January/February 2022 - 16
APR January/February 2022 - 17
APR January/February 2022 - 18
APR January/February 2022 - 19
APR January/February 2022 - 20
APR January/February 2022 - 21
APR January/February 2022 - 22
APR January/February 2022 - 23
APR January/February 2022 - 24
APR January/February 2022 - 25
APR January/February 2022 - 26
APR January/February 2022 - 27
APR January/February 2022 - 28
APR January/February 2022 - 29
APR January/February 2022 - 30
APR January/February 2022 - 31
APR January/February 2022 - 32
APR January/February 2022 - 33
APR January/February 2022 - 34
APR January/February 2022 - 35
APR January/February 2022 - 36
APR January/February 2022 - 37
APR January/February 2022 - 38
APR January/February 2022 - 39
APR January/February 2022 - 40
APR January/February 2022 - 41
APR January/February 2022 - 42
APR January/February 2022 - 43
APR January/February 2022 - 44
APR January/February 2022 - 45
APR January/February 2022 - 46
APR January/February 2022 - 47
APR January/February 2022 - 48
APR January/February 2022 - 49
APR January/February 2022 - 50
APR January/February 2022 - 51
APR January/February 2022 - 52
APR January/February 2022 - 53
APR January/February 2022 - 54
APR January/February 2022 - 55
APR January/February 2022 - 56
APR January/February 2022 - 57
APR January/February 2022 - 58
APR January/February 2022 - 59
APR January/February 2022 - 60
APR January/February 2022 - 61
APR January/February 2022 - 62
APR January/February 2022 - 63
APR January/February 2022 - 64
APR January/February 2022 - 65
APR January/February 2022 - 66
APR January/February 2022 - 67
APR January/February 2022 - 68
APR January/February 2022 - 69
APR January/February 2022 - 70
APR January/February 2022 - 71
APR January/February 2022 - 72
APR January/February 2022 - 73
APR January/February 2022 - 74
APR January/February 2022 - 75
APR January/February 2022 - 76
APR January/February 2022 - 77
APR January/February 2022 - 78
APR January/February 2022 - 79
APR January/February 2022 - 80
APR January/February 2022 - 81
APR January/February 2022 - 82
APR January/February 2022 - 83
APR January/February 2022 - 84
APR January/February 2022 - Cover3
APR January/February 2022 - Cover4
https://www.nxtbookmedia.com